HOVON161: Comparison of Point-of-care Produced CAR T-cell With Commercial CAR T-cells in Patients With R/R LBCL (clinicaltrials.gov) - Oct 6, 2026 - P2 | N=340 | Active, not recruiting | Sponsor: University Medical Center Groningen | Recruiting ➔ Active, not recruiting | Trial completion date: Dec 2027 ➔ Sep 2028 | Trial primary completion date: Dec 2025 ➔ Jun 2027
Enrollment closed • Head-to-Head • Trial completion date • Trial primary completion date • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • BCL2 • BCL6
|